埃塞俄比亚东南部 Covid-19 患者院内死亡或康复时间的竞争风险生存分析:一项基于医院的多站点研究

Addis Wordofa, Ayalneh Demissie, Abdurehman Kalu, Abdurehman Tune, Mohammed Suleiman, Abay Kibret, Zerihun Abera, Yonas Mulugeta, Details
{"title":"埃塞俄比亚东南部 Covid-19 患者院内死亡或康复时间的竞争风险生存分析:一项基于医院的多站点研究","authors":"Addis Wordofa, Ayalneh Demissie, Abdurehman Kalu, Abdurehman Tune, Mohammed Suleiman, Abay Kibret, Zerihun Abera, Yonas Mulugeta, Details","doi":"10.1101/2024.06.04.24308446","DOIUrl":null,"url":null,"abstract":"Background: To date, survival data on risk factors for COVID-19 mortality in south-Ethiopia is limited, and none of the published survival studies have used a competing risk approach. This study aims to identify risk factors for in-hospital mortality in COVID-19 patients hospitalized at one of the six hospitals in southeast-Ethiopia, considering recovery as a competing risk. Methods: This observational multisite study included a medical record of 827 confirmed SARS-CoV-2 cases hospitalized at one of the six hospitals in southeast-Ethiopia from October 1, 2022 to May 31, 2023. We compiled data on the patients' socio-demographic characteristics, clinical manifestation, comorbidity, treatment status, treatment outcomes, and length of stay. We performed a Cox regression analysis for competing risks, presenting cause-specific hazard ratios (HRcs) for the effect of preselected factors on the absolute risk of death and recovery. Results: 827 patients were included (51.9% male; median age 50 years, IQR: 38-65). Patients were hospitalized for a median duration of 5 days (IQR: 1-7); 139 (17%) of them died, while 516 (62%) were recovered and discharged alive, the rest 172 (21%) were censored. Patients with higher age (HRcs 2.62, 95% CI 1.29-5.29), immune-compromised state (HRcs 1.46, 95% CI 1.08-1.98) had increased risk of death, whereas male sex paradoxically (HRcs 0.45, 95% CI 0.22-0.91) associated with decreased risk of death. We found no increased mortality risk in diabetes patients. Conclusion: This competing risk survival analysis allows us to corroborate specific pattern of risk factors about COVID-19 mortality and its progression among different groups of individuals (differentiated by age and immune-compromised state). 62% presenting cases recovered within a median duration of 5 days; where as 17% die within the first 72 hours, most with immune-compromised conditions. This should be considered while planning and allocating the distribution of care services for effective health service delivery.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Competing Risk Survival analysis of time to in-hospital mortality or Recovery among Covid-19 Patients in South-East Ethiopia: a hospital-based multisite study\",\"authors\":\"Addis Wordofa, Ayalneh Demissie, Abdurehman Kalu, Abdurehman Tune, Mohammed Suleiman, Abay Kibret, Zerihun Abera, Yonas Mulugeta, Details\",\"doi\":\"10.1101/2024.06.04.24308446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: To date, survival data on risk factors for COVID-19 mortality in south-Ethiopia is limited, and none of the published survival studies have used a competing risk approach. This study aims to identify risk factors for in-hospital mortality in COVID-19 patients hospitalized at one of the six hospitals in southeast-Ethiopia, considering recovery as a competing risk. Methods: This observational multisite study included a medical record of 827 confirmed SARS-CoV-2 cases hospitalized at one of the six hospitals in southeast-Ethiopia from October 1, 2022 to May 31, 2023. We compiled data on the patients' socio-demographic characteristics, clinical manifestation, comorbidity, treatment status, treatment outcomes, and length of stay. We performed a Cox regression analysis for competing risks, presenting cause-specific hazard ratios (HRcs) for the effect of preselected factors on the absolute risk of death and recovery. Results: 827 patients were included (51.9% male; median age 50 years, IQR: 38-65). Patients were hospitalized for a median duration of 5 days (IQR: 1-7); 139 (17%) of them died, while 516 (62%) were recovered and discharged alive, the rest 172 (21%) were censored. Patients with higher age (HRcs 2.62, 95% CI 1.29-5.29), immune-compromised state (HRcs 1.46, 95% CI 1.08-1.98) had increased risk of death, whereas male sex paradoxically (HRcs 0.45, 95% CI 0.22-0.91) associated with decreased risk of death. We found no increased mortality risk in diabetes patients. Conclusion: This competing risk survival analysis allows us to corroborate specific pattern of risk factors about COVID-19 mortality and its progression among different groups of individuals (differentiated by age and immune-compromised state). 62% presenting cases recovered within a median duration of 5 days; where as 17% die within the first 72 hours, most with immune-compromised conditions. This should be considered while planning and allocating the distribution of care services for effective health service delivery.\",\"PeriodicalId\":506788,\"journal\":{\"name\":\"medRxiv\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.06.04.24308446\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.06.04.24308446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:迄今为止,有关埃塞俄比亚南部 COVID-19 死亡率风险因素的生存数据十分有限,而且已发表的生存研究均未采用竞争风险方法。本研究旨在确定在埃塞俄比亚东南部六家医院之一住院的 COVID-19 患者院内死亡的风险因素,并将康复视为竞争风险。研究方法:这项多地点观察性研究收集了 2022 年 10 月 1 日至 2023 年 5 月 31 日期间在埃塞俄比亚东南部六家医院之一住院的 827 例经确诊的 SARS-CoV-2 病例的医疗记录。我们收集了患者的社会人口学特征、临床表现、合并症、治疗情况、治疗结果和住院时间等数据。我们对竞争风险进行了 Cox 回归分析,得出了预选因素对死亡和康复绝对风险影响的特定病因危险比 (HRcs)。结果共纳入 827 名患者(51.9% 为男性;中位年龄 50 岁,IQR:38-65)。患者住院时间中位数为 5 天(IQR:1-7);其中 139 人(17%)死亡,516 人(62%)康复出院,其余 172 人(21%)被排除在外。年龄越大(HRcs 2.62,95% CI 1.29-5.29)、免疫力越差(HRcs 1.46,95% CI 1.08-1.98)的患者死亡风险越高,而男性(HRcs 0.45,95% CI 0.22-0.91)则与死亡风险降低有关。我们没有发现糖尿病患者的死亡风险增加。结论这种竞争风险生存分析使我们能够证实不同人群(按年龄和免疫受损状态区分)中 COVID-19 死亡率及其进展的特定风险因素模式。62%的病例在中位 5 天内痊愈,17%的病例在 72 小时内死亡,其中大部分为免疫力低下者。在规划和分配护理服务以有效提供医疗服务时,应考虑到这一点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Competing Risk Survival analysis of time to in-hospital mortality or Recovery among Covid-19 Patients in South-East Ethiopia: a hospital-based multisite study
Background: To date, survival data on risk factors for COVID-19 mortality in south-Ethiopia is limited, and none of the published survival studies have used a competing risk approach. This study aims to identify risk factors for in-hospital mortality in COVID-19 patients hospitalized at one of the six hospitals in southeast-Ethiopia, considering recovery as a competing risk. Methods: This observational multisite study included a medical record of 827 confirmed SARS-CoV-2 cases hospitalized at one of the six hospitals in southeast-Ethiopia from October 1, 2022 to May 31, 2023. We compiled data on the patients' socio-demographic characteristics, clinical manifestation, comorbidity, treatment status, treatment outcomes, and length of stay. We performed a Cox regression analysis for competing risks, presenting cause-specific hazard ratios (HRcs) for the effect of preselected factors on the absolute risk of death and recovery. Results: 827 patients were included (51.9% male; median age 50 years, IQR: 38-65). Patients were hospitalized for a median duration of 5 days (IQR: 1-7); 139 (17%) of them died, while 516 (62%) were recovered and discharged alive, the rest 172 (21%) were censored. Patients with higher age (HRcs 2.62, 95% CI 1.29-5.29), immune-compromised state (HRcs 1.46, 95% CI 1.08-1.98) had increased risk of death, whereas male sex paradoxically (HRcs 0.45, 95% CI 0.22-0.91) associated with decreased risk of death. We found no increased mortality risk in diabetes patients. Conclusion: This competing risk survival analysis allows us to corroborate specific pattern of risk factors about COVID-19 mortality and its progression among different groups of individuals (differentiated by age and immune-compromised state). 62% presenting cases recovered within a median duration of 5 days; where as 17% die within the first 72 hours, most with immune-compromised conditions. This should be considered while planning and allocating the distribution of care services for effective health service delivery.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Reemergence of Oropouche virus between 2023 and 2024 in Brazil Towards Personalized Breast Cancer Risk Management: A Thai Cohort Study on Polygenic Risk Scores Hot Spring Residency and Disease Association: a Crossover Gene-Environment Interaction (GxE) Study in Taiwan Evaluation of the diagnostic value of YiDiXie™-SS, YiDiXie™-HS and YiDiXie™-D in renal cancer Dual exposure-by-polygenic score interactions highlight disparities across social groups in the proportion needed to benefit
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1